Dysport for the Treatment of OMD

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

February 8, 2017

Study Completion Date

February 8, 2017

Conditions
Oral DystoniaTardive Dystonia
Interventions
DRUG

Low Dose - AbobotulinumtoxinA

"Participants will receive low dose AbobotulinumtoxinA injections. Location of injections will be determined by the clinician to treat the individual's dystonic symptom.~Muscles that may be included for in injection for OMD with Jaw Closing:~Medial Pterygoid 50 units, Masseter 25 units~Muscles that may be included in injection for OMD with Jaw Opening:~Lateral Pterygoid 50 units, Anterior digastrics 10 units~Muscle that will be included in injection for OMD with Tongue Protrusion:~Genioglossus 7.5 units"

Trial Locations (1)

30329

Wesley Woods Health Center; Emory University Hospital, Atlanta

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Ipsen

INDUSTRY

lead

Emory University

OTHER